arrow
L

Laurence Corash

universites de strasbourg etablissements associes
H指数:57
被引数:8,747

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A randomized, double-blind, controlled, parallel group study with amustaline/glutathione pathogen reduced red blood cells in regions at potential risk for Zika virus transfusion-transmitted infections (RedeS Study)-protocol for a phase 3 clinical trial

一项关于使用氨脲嘧啶/谷胱甘肽途径病原体灭活血红蛋白红细胞预防寨卡病毒输血传播感染的随机、双盲、对照、平行组研究(RedeS研究)——一项III期临床试验方案

2026-05-010
PRE
Amustaline/glutathione pathogen-reduced red cell hemoglobin utilization in complex cardiac surgery: A post hoc analysis of the phase 3 ReCePI trial

Amustaline/谷胱甘肽病原体灭活红细胞血红蛋白在复杂心脏手术中的利用:ReCePI三期试验的事后分析

2025-11-010
PRE
A novel acridine flow cytometry marker to track post-transfusion amustaline/glutathione pathogen-reduced red blood cell survival in sickle cell disease patients

一种新型的吖啶流式细胞术标记物,用于追踪镰状细胞病患者输血后经病原体灭活的阿姆斯他林/谷胱甘肽红细胞的存活情况

2025-04-180
OAAI
Transfusion Efficacy and Safety of Amustaline/Glutathione Pathogen-Reduced Red Blood Cells: Results of a Randomized, Controlled Phase III Trial

Amustaline/Glutathione病原体减少红细胞的输注有效性与安全性:一项随机、对照III期试验的结果

BLOOD
IF23.1
2024-11-050
PRE
Acute pulmonary injury in hematology patients supported with pathogen-reduced and conventional platelet components

减少病原体和常规血小板成分支持的血液病患者的急性肺损伤

2024-05-140
OAAI
Detection of neutralizing antibodies against multiple SARS-CoV-2 strains in dried blood spots using cell-free PCR
2022-07-2110
OAAI
Analysis of SARS-CoV-2 antibodies in COVID-19 convalescent blood using a coronavirus antigen microarray
2021-01-04125
OAAI